Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EMA’s CHMP recommends Merck and Pfizer's cancer drug avelumab for approval

pharmaceutical-technologyJuly 25, 2017

Tag: cancer drug , avelumab , EMA’s CHMP

PharmaSources Customer Service